世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

中国 合成プロゲステロンProgの市場レポートと予測 2021-2027年

中国 合成プロゲステロンProgの市場レポートと予測 2021-2027年


China Synthetic Progesterone Prog Market Report & Forecast 2021-2027

This report contains market size and forecasts of Synthetic Progesterone Prog in China, including the following market information: China Synthetic Progesterone Prog Market Revenue, 2016-2021, 202... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2021年10月14日 US$3,400
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

This report contains market size and forecasts of Synthetic Progesterone Prog in China, including the following market information:
China Synthetic Progesterone Prog Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Synthetic Progesterone Prog Market Sales, 2016-2021, 2022-2027, (Kiloton)
China top five Synthetic Progesterone Prog companies in 2020 (%)
The global Synthetic Progesterone Prog market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Synthetic Progesterone Prog market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Synthetic Progesterone Prog manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Synthetic Progesterone Prog Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
China Synthetic Progesterone Prog Market Segment Percentages, By Type, 2020 (%)
Injectable
Oral
Others

China Synthetic Progesterone Prog Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
China Synthetic Progesterone Prog Market Segment Percentages, By Application, 2020 (%)
Menstrual Disorder
Dysmenorrhea and Premenstrual Syndrome
Premenopausal Disorder
Habitual Abortion
Pregnancy

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Synthetic Progesterone Prog revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Synthetic Progesterone Prog revenues share in China market, 2020 (%)
Key companies Synthetic Progesterone Prog sales in China market, 2016-2021 (Estimated), (Kiloton)
Key companies Synthetic Progesterone Prog sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
BIONPHARMA INC.
Teva Pharmaceutical Industries Ltd.
Aquatic Remedies
Sofgen Pharmaceuticals
Virtus Pharmaceuticals
Intas Pharmaceuticals Limited
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shanghai General Pharmaceutical



ページTOPに戻る


目次

1 Introduction to Research & Analysis Reports
1.1 Synthetic Progesterone Prog Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Synthetic Progesterone Prog Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Synthetic Progesterone Prog Overall Market Size
2.1 China Synthetic Progesterone Prog Market Size: 2021 VS 2027
2.2 China Synthetic Progesterone Prog Revenue, Prospects & Forecasts: 2016-2027
2.3 China Synthetic Progesterone Prog Sales: 2016-2027

3 Company Landscape
3.1 Top Synthetic Progesterone Prog Players in China Market
3.2 Top China Synthetic Progesterone Prog Companies Ranked by Revenue
3.3 China Synthetic Progesterone Prog Revenue by Companies
3.4 China Synthetic Progesterone Prog Sales by Companies
3.5 China Synthetic Progesterone Prog Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Synthetic Progesterone Prog Companies in China Market, by Revenue in 2020
3.7 Manufacturers Synthetic Progesterone Prog Product Type
3.8 Tier 1, Tier 2 and Tier 3 Synthetic Progesterone Prog Players in China Market
3.8.1 List of Tier 1 Synthetic Progesterone Prog Companies in China
3.8.2 List of Tier 2 and Tier 3 Synthetic Progesterone Prog Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Synthetic Progesterone Prog Market Size Markets, 2021 & 2027
4.1.2 Injectable
4.1.3 Oral
4.1.4 Others
4.2 By Type - China Synthetic Progesterone Prog Revenue & Forecasts
4.2.1 By Type - China Synthetic Progesterone Prog Revenue, 2016-2021
4.2.2 By Type - China Synthetic Progesterone Prog Revenue, 2022-2027
4.2.3 By Type - China Synthetic Progesterone Prog Revenue Market Share, 2016-2027
4.3 By Type - China Synthetic Progesterone Prog Sales & Forecasts
4.3.1 By Type - China Synthetic Progesterone Prog Sales, 2016-2021
4.3.2 By Type - China Synthetic Progesterone Prog Sales, 2022-2027
4.3.3 By Type - China Synthetic Progesterone Prog Sales Market Share, 2016-2027
4.4 By Type - China Synthetic Progesterone Prog Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Synthetic Progesterone Prog Market Size, 2021 & 2027
5.1.2 Menstrual Disorder
5.1.3 Dysmenorrhea and Premenstrual Syndrome
5.1.4 Premenopausal Disorder
5.1.5 Habitual Abortion
5.1.6 Pregnancy
5.2 By Application - China Synthetic Progesterone Prog Revenue & Forecasts
5.2.1 By Application - China Synthetic Progesterone Prog Revenue, 2016-2021
5.2.2 By Application - China Synthetic Progesterone Prog Revenue, 2022-2027
5.2.3 By Application - China Synthetic Progesterone Prog Revenue Market Share, 2016-2027
5.3 By Application - China Synthetic Progesterone Prog Sales & Forecasts
5.3.1 By Application - China Synthetic Progesterone Prog Sales, 2016-2021
5.3.2 By Application - China Synthetic Progesterone Prog Sales, 2022-2027
5.3.3 By Application - China Synthetic Progesterone Prog Sales Market Share, 2016-2027
5.4 By Application - China Synthetic Progesterone Prog Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Overview
6.1.3 Merck Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.1.4 Merck Synthetic Progesterone Prog Product Description
6.1.5 Merck Recent Developments
6.2 BIONPHARMA INC.
6.2.1 BIONPHARMA INC. Corporation Information
6.2.2 BIONPHARMA INC. Overview
6.2.3 BIONPHARMA INC. Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.2.4 BIONPHARMA INC. Synthetic Progesterone Prog Product Description
6.2.5 BIONPHARMA INC. Recent Developments
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd. Overview
6.3.3 Teva Pharmaceutical Industries Ltd. Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.3.4 Teva Pharmaceutical Industries Ltd. Synthetic Progesterone Prog Product Description
6.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
6.4 Aquatic Remedies
6.4.1 Aquatic Remedies Corporation Information
6.4.2 Aquatic Remedies Overview
6.4.3 Aquatic Remedies Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.4.4 Aquatic Remedies Synthetic Progesterone Prog Product Description
6.4.5 Aquatic Remedies Recent Developments
6.5 Sofgen Pharmaceuticals
6.5.1 Sofgen Pharmaceuticals Corporation Information
6.5.2 Sofgen Pharmaceuticals Overview
6.5.3 Sofgen Pharmaceuticals Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.5.4 Sofgen Pharmaceuticals Synthetic Progesterone Prog Product Description
6.5.5 Sofgen Pharmaceuticals Recent Developments
6.6 Virtus Pharmaceuticals
6.6.1 Virtus Pharmaceuticals Corporation Information
6.6.2 Virtus Pharmaceuticals Overview
6.6.3 Virtus Pharmaceuticals Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.6.4 Virtus Pharmaceuticals Synthetic Progesterone Prog Product Description
6.6.5 Virtus Pharmaceuticals Recent Developments
6.7 Intas Pharmaceuticals Limited
6.7.1 Intas Pharmaceuticals Limited Corporation Information
6.7.2 Intas Pharmaceuticals Limited Overview
6.7.3 Intas Pharmaceuticals Limited Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.7.4 Intas Pharmaceuticals Limited Synthetic Progesterone Prog Product Description
6.7.5 Intas Pharmaceuticals Limited Recent Developments
6.8 Hubei Dongxin Pharmaceutical
6.8.1 Hubei Dongxin Pharmaceutical Corporation Information
6.8.2 Hubei Dongxin Pharmaceutical Overview
6.8.3 Hubei Dongxin Pharmaceutical Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.8.4 Hubei Dongxin Pharmaceutical Synthetic Progesterone Prog Product Description
6.8.5 Hubei Dongxin Pharmaceutical Recent Developments
6.9 Tianjin Jinyao Pharmaceutical
6.9.1 Tianjin Jinyao Pharmaceutical Corporation Information
6.9.2 Tianjin Jinyao Pharmaceutical Overview
6.9.3 Tianjin Jinyao Pharmaceutical Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.9.4 Tianjin Jinyao Pharmaceutical Synthetic Progesterone Prog Product Description
6.9.5 Tianjin Jinyao Pharmaceutical Recent Developments
6.10 Shanghai General Pharmaceutical
6.10.1 Shanghai General Pharmaceutical Corporation Information
6.10.2 Shanghai General Pharmaceutical Overview
6.10.3 Shanghai General Pharmaceutical Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.10.4 Shanghai General Pharmaceutical Synthetic Progesterone Prog Product Description
6.10.5 Shanghai General Pharmaceutical Recent Developments

7 China Synthetic Progesterone Prog Production Capacity, Analysis
7.1 China Synthetic Progesterone Prog Production Capacity, 2016-2027
7.2 Synthetic Progesterone Prog Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Synthetic Progesterone Prog Supply Chain Analysis
9.1 Synthetic Progesterone Prog Industry Value Chain
9.2 Synthetic Progesterone Prog Upstream Market
9.3 Synthetic Progesterone Prog Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Synthetic Progesterone Prog Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

 

ページTOPに戻る


 

Summary

This report contains market size and forecasts of Synthetic Progesterone Prog in China, including the following market information:
China Synthetic Progesterone Prog Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Synthetic Progesterone Prog Market Sales, 2016-2021, 2022-2027, (Kiloton)
China top five Synthetic Progesterone Prog companies in 2020 (%)
The global Synthetic Progesterone Prog market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Synthetic Progesterone Prog market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Synthetic Progesterone Prog manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Synthetic Progesterone Prog Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
China Synthetic Progesterone Prog Market Segment Percentages, By Type, 2020 (%)
Injectable
Oral
Others

China Synthetic Progesterone Prog Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)
China Synthetic Progesterone Prog Market Segment Percentages, By Application, 2020 (%)
Menstrual Disorder
Dysmenorrhea and Premenstrual Syndrome
Premenopausal Disorder
Habitual Abortion
Pregnancy

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Synthetic Progesterone Prog revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Synthetic Progesterone Prog revenues share in China market, 2020 (%)
Key companies Synthetic Progesterone Prog sales in China market, 2016-2021 (Estimated), (Kiloton)
Key companies Synthetic Progesterone Prog sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
BIONPHARMA INC.
Teva Pharmaceutical Industries Ltd.
Aquatic Remedies
Sofgen Pharmaceuticals
Virtus Pharmaceuticals
Intas Pharmaceuticals Limited
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shanghai General Pharmaceutical



ページTOPに戻る


Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Synthetic Progesterone Prog Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Synthetic Progesterone Prog Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Synthetic Progesterone Prog Overall Market Size
2.1 China Synthetic Progesterone Prog Market Size: 2021 VS 2027
2.2 China Synthetic Progesterone Prog Revenue, Prospects & Forecasts: 2016-2027
2.3 China Synthetic Progesterone Prog Sales: 2016-2027

3 Company Landscape
3.1 Top Synthetic Progesterone Prog Players in China Market
3.2 Top China Synthetic Progesterone Prog Companies Ranked by Revenue
3.3 China Synthetic Progesterone Prog Revenue by Companies
3.4 China Synthetic Progesterone Prog Sales by Companies
3.5 China Synthetic Progesterone Prog Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Synthetic Progesterone Prog Companies in China Market, by Revenue in 2020
3.7 Manufacturers Synthetic Progesterone Prog Product Type
3.8 Tier 1, Tier 2 and Tier 3 Synthetic Progesterone Prog Players in China Market
3.8.1 List of Tier 1 Synthetic Progesterone Prog Companies in China
3.8.2 List of Tier 2 and Tier 3 Synthetic Progesterone Prog Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Synthetic Progesterone Prog Market Size Markets, 2021 & 2027
4.1.2 Injectable
4.1.3 Oral
4.1.4 Others
4.2 By Type - China Synthetic Progesterone Prog Revenue & Forecasts
4.2.1 By Type - China Synthetic Progesterone Prog Revenue, 2016-2021
4.2.2 By Type - China Synthetic Progesterone Prog Revenue, 2022-2027
4.2.3 By Type - China Synthetic Progesterone Prog Revenue Market Share, 2016-2027
4.3 By Type - China Synthetic Progesterone Prog Sales & Forecasts
4.3.1 By Type - China Synthetic Progesterone Prog Sales, 2016-2021
4.3.2 By Type - China Synthetic Progesterone Prog Sales, 2022-2027
4.3.3 By Type - China Synthetic Progesterone Prog Sales Market Share, 2016-2027
4.4 By Type - China Synthetic Progesterone Prog Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Synthetic Progesterone Prog Market Size, 2021 & 2027
5.1.2 Menstrual Disorder
5.1.3 Dysmenorrhea and Premenstrual Syndrome
5.1.4 Premenopausal Disorder
5.1.5 Habitual Abortion
5.1.6 Pregnancy
5.2 By Application - China Synthetic Progesterone Prog Revenue & Forecasts
5.2.1 By Application - China Synthetic Progesterone Prog Revenue, 2016-2021
5.2.2 By Application - China Synthetic Progesterone Prog Revenue, 2022-2027
5.2.3 By Application - China Synthetic Progesterone Prog Revenue Market Share, 2016-2027
5.3 By Application - China Synthetic Progesterone Prog Sales & Forecasts
5.3.1 By Application - China Synthetic Progesterone Prog Sales, 2016-2021
5.3.2 By Application - China Synthetic Progesterone Prog Sales, 2022-2027
5.3.3 By Application - China Synthetic Progesterone Prog Sales Market Share, 2016-2027
5.4 By Application - China Synthetic Progesterone Prog Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Overview
6.1.3 Merck Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.1.4 Merck Synthetic Progesterone Prog Product Description
6.1.5 Merck Recent Developments
6.2 BIONPHARMA INC.
6.2.1 BIONPHARMA INC. Corporation Information
6.2.2 BIONPHARMA INC. Overview
6.2.3 BIONPHARMA INC. Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.2.4 BIONPHARMA INC. Synthetic Progesterone Prog Product Description
6.2.5 BIONPHARMA INC. Recent Developments
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd. Overview
6.3.3 Teva Pharmaceutical Industries Ltd. Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.3.4 Teva Pharmaceutical Industries Ltd. Synthetic Progesterone Prog Product Description
6.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
6.4 Aquatic Remedies
6.4.1 Aquatic Remedies Corporation Information
6.4.2 Aquatic Remedies Overview
6.4.3 Aquatic Remedies Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.4.4 Aquatic Remedies Synthetic Progesterone Prog Product Description
6.4.5 Aquatic Remedies Recent Developments
6.5 Sofgen Pharmaceuticals
6.5.1 Sofgen Pharmaceuticals Corporation Information
6.5.2 Sofgen Pharmaceuticals Overview
6.5.3 Sofgen Pharmaceuticals Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.5.4 Sofgen Pharmaceuticals Synthetic Progesterone Prog Product Description
6.5.5 Sofgen Pharmaceuticals Recent Developments
6.6 Virtus Pharmaceuticals
6.6.1 Virtus Pharmaceuticals Corporation Information
6.6.2 Virtus Pharmaceuticals Overview
6.6.3 Virtus Pharmaceuticals Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.6.4 Virtus Pharmaceuticals Synthetic Progesterone Prog Product Description
6.6.5 Virtus Pharmaceuticals Recent Developments
6.7 Intas Pharmaceuticals Limited
6.7.1 Intas Pharmaceuticals Limited Corporation Information
6.7.2 Intas Pharmaceuticals Limited Overview
6.7.3 Intas Pharmaceuticals Limited Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.7.4 Intas Pharmaceuticals Limited Synthetic Progesterone Prog Product Description
6.7.5 Intas Pharmaceuticals Limited Recent Developments
6.8 Hubei Dongxin Pharmaceutical
6.8.1 Hubei Dongxin Pharmaceutical Corporation Information
6.8.2 Hubei Dongxin Pharmaceutical Overview
6.8.3 Hubei Dongxin Pharmaceutical Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.8.4 Hubei Dongxin Pharmaceutical Synthetic Progesterone Prog Product Description
6.8.5 Hubei Dongxin Pharmaceutical Recent Developments
6.9 Tianjin Jinyao Pharmaceutical
6.9.1 Tianjin Jinyao Pharmaceutical Corporation Information
6.9.2 Tianjin Jinyao Pharmaceutical Overview
6.9.3 Tianjin Jinyao Pharmaceutical Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.9.4 Tianjin Jinyao Pharmaceutical Synthetic Progesterone Prog Product Description
6.9.5 Tianjin Jinyao Pharmaceutical Recent Developments
6.10 Shanghai General Pharmaceutical
6.10.1 Shanghai General Pharmaceutical Corporation Information
6.10.2 Shanghai General Pharmaceutical Overview
6.10.3 Shanghai General Pharmaceutical Synthetic Progesterone Prog Sales and Revenue in China Market (2016-2021)
6.10.4 Shanghai General Pharmaceutical Synthetic Progesterone Prog Product Description
6.10.5 Shanghai General Pharmaceutical Recent Developments

7 China Synthetic Progesterone Prog Production Capacity, Analysis
7.1 China Synthetic Progesterone Prog Production Capacity, 2016-2027
7.2 Synthetic Progesterone Prog Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Synthetic Progesterone Prog Supply Chain Analysis
9.1 Synthetic Progesterone Prog Industry Value Chain
9.2 Synthetic Progesterone Prog Upstream Market
9.3 Synthetic Progesterone Prog Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Synthetic Progesterone Prog Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_691419fd14e4c0_44706041() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630